1375303-26-6Relevant articles and documents
INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE
-
Paragraph 00460, (2017/12/29)
Disclosed herein are inhibitors of IRAK protein kinase of formula (I). Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the IRAK inhibitors are described, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.